Hong Kong Morning Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Morning Sun.

Press releases published on November 5, 2026

Nov. 5, 2026

TCMS selects Tribe Payments as its acquirer processing partner for Asia-Pacific

Indeterminate EIN Presswire

Nov. 5, 2026

Copley Acquisition Corp Announces Shareholder Approval of Extension of Termination Date and Contribution to Trust Account to Extend Termination Date

Indeterminate GlobeNewswire

Nov. 5, 2026

Trust Anchor Service and AML Watcher Make Screening Results Verifiable

Indeterminate EIN Presswire

Nov. 5, 2026

MoneyBuddy 推出免費貸款比較平台，涵蓋逾30間貸款機構，實際年利率由1.8%起

Indeterminate EIN Presswire

Nov. 5, 2026

香港旅行社東瀛遊推出全新年輕旅行品牌Hii-Fly 專為25至45歲旅客而設｜第一季首站斯里蘭卡

Indeterminate EIN Presswire

Nov. 5, 2026

BTCC Copy Trading Surpasses 680,000 Users, With Cumulative Copy Trading Earnings Exceeding $530 Million

Indeterminate GlobeNewswire

Nov. 5, 2026

Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics

Indeterminate GlobeNewswire

Nov. 5, 2026

Koku Inc. Opens Tokyo's Kozushima to International Travelers for the First Time

Indeterminate EIN Presswire

Nov. 5, 2026

Wellchange Holdings Company Limited Announces 1-for-10 Reverse Stock Split Effective November 9, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

3 E Network Partners with Zhengguangtong Logistics to Develop Asset-Light AI Compute Supply Chain Network

Indeterminate GlobeNewswire

Nov. 5, 2026

Charming Medical Limited Announces Receipt of Nasdaq Delisting Determination Notice.

Indeterminate GlobeNewswire

Nov. 5, 2026

GigaCloud Technology Inc Announces Third Quarter and Nine Months Ended September 30, 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Futu to Report Third Quarter 2026 Financial Results on November 19, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire